3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Active not recruiting
3
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Sarcoma
3
Prostatic Neoplasms
3
Stomach Neoplasms
2
Lung Neoplasms
2
Head and Neck Neoplasms
2
Breast Neoplasms
2
Thyroid Neoplasms
1
Thrombosis
1
Stroke
1
Skin Neoplasms
1
Sarcoma, Kaposi
1
Rhabdomyosarcoma
1
Resectable Pancreatic Carcinoma
1
Rectal Neoplasms
1
Pelvic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Nevus, Pigmented
1
Neoplasms
1
Mesothelioma, Malignant
1
Melanoma
1
Liver Neoplasms
1
Liposarcoma
1
Glioma
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Interventions
Paclitaxel
20
Carboplatin
16
liposomal doxorubicin
10
Bevacizumab
10
Gemcitabine
8
Topotecan
7
Taxes
7
Cisplatin
7
pembrolizumab
6
Doxorubicin
5
Cyclophosphamide
5
Nivolumab
4
fludarabine
3
Oxaliplatin
3
Immunoglobulin G
3
Hyperthermic Intraperitoneal Chemotherapy
3
Disulfides
3
Cytoreduction Surgical Procedures
3
trebananib
2
talazoparib
2
rucaparib
2
peginterferon alfa-2b
2
olaparib
2
fludarabine phosphate
2
aldesleukin
2
Surgical Procedures, Operative
2
STA 9090
2
Platinum
2
Lenalidomide
2
Irinotecan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Fallopian Tube Neoplasms
×
X-Rays
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled